Both in Biotechnology
BioStem Technologies vs aTyr Pharma
Over the past year BSEM returned −73.3% and ATYR returned −64.1%; their daily moves had a correlation of 0.25.
BSEM −73.3% ATYR −64.1%Growth of $1, one year, split-adjusted
| Metric | BSEM | ATYR |
|---|---|---|
| Price | $1.15 | $6.18 |
| Market cap | $21.5M | $15.4M |
| Today | 0.00% | −6.79% |
| 1 month | −53.4% | −45.5% |
| 6 months | — | −85.1% |
| Year to date | — | −80.3% |
| 1 year | — | −82.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 81.3× |
| Net cash | — | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | — | 1,072.3% |
| Short % of float | 2.3% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).